Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Metastatic Breast Cancer
Sponsor: UNICANCER
Collaborators: Roche Pharma AG|Pierre Fabre Laboratories|Pfizer|AstraZeneca|Merck Sharp & Dohme LLC|Eisai Inc.|Daiichi Sankyo|Eli Lilly and Company|Gilead Sciences|Seagen Inc.